Dr. Praveen Kulkarni is a highly skilled interventional cardiologist with over 18 years of experience in advanced cardiovascular care. He specialises in complex and high-risk coronary interventions (CHIP), structural cardiology procedures, and device implantations. Trained at premier institutions like PGIMER Chandigarh and GB Pant Hospital, he has contributed to pioneering work in bio-absorbable stents in India. With strong expertise in both interventional and non-invasive cardiology, he is recognised for clinical excellence, research contributions and patient-centric cardiac care.

Educational Qualifications:

• DM (Cardiology) – Govind Ballabh Pant Hospital, Maulana Azad Medical College, New Delhi (2011)
• MD (Medicine) – Postgraduate Institute of Medical Education & Research (PGIMER), Chandigarh (2007)
• MBBS – Jawaharlal Nehru Medical College, Belagavi, Rajiv Gandhi University of Health Sciences (2002)

Professional Experience:

• Director – Interventional Cardiology, Nanavati Max Super Speciality Hospital, Mumbai (Jun 2025 – Present)
• Consultant – Cardiology, Gleneagles Hospitals, Mumbai (Mar 2013 – Jun 2025)
• Consultant – Cardiology, Asian Heart Institute, Mumbai (Nov 2011 – Mar 2013)
• Senior Resident – Cardiology, GB Pant Hospital, New Delhi (Jun 2008 – Oct 2011)
• Junior Resident – General Medicine, PGIMER, Chandigarh (Jul 2004 – Jun 2007)

Professional Memberships:

• Indian Medical Association (IMA)
• Cardiological Society of India (CSI)
• Maharashtra Medical Council (MMC)
• Karnataka Medical Council (KMC)
• Delhi Medical Council (DMC)

Awards & Achievements:

• Among the first physicians in India to use bio-absorbable stents
• Ranked 1st in MD (Medicine), PGIMER
• Ranked 9th in All-India MD/MS Entrance (PGIMER)
• Ranked 5th in All-India DM Entrance (Delhi University)
• Certificate in Research Methodology & Biostatistics, PGIMER
• Delivered 100+ community health talks and outreach sessions

Research Papers & Publications:

• Prediction of subclinical left-ventricular dysfunction using strain-rate imaging in rheumatic mitral-stenosis patients. Indian Heart Journal 62 (6): 463-529
• Exercise-stress echocardiography after revascularisation: a single-centre study. Indian Heart Journal 64 (2012): S81-S94
• Comparison of bivalirudin monotherapy with unfractionated heparin + GpIIb/IIIa inhibition in USA/NSTEMI PCI patients. Indian Heart Journal 64 (2012): S69
• Poster: Clinical significance of NT-proBNP in evaluating functional status and right-heart performance in primary pulmonary hypertension (Cardiological Society of India, Kochi)
• Poster: Right-ventricular tissue-Doppler imaging in primary pulmonary hypertension & Eisenmenger’s syndrome—correlation with right-heart catheterisation and NT-proBNP (Cardiological Society of India, Kolkata)
• Co-investigator, SERAPHIN long-term extension study on ACT-064992 in pulmonary arterial hypertension; key findings published in NEJM (“Macitentan and morbidity and mortality in pulmonary arterial hypertension”)
• Thesis: Echocardiographic comparison of primary pulmonary hypertension and Eisenmenger’s syndrome with right-heart catheterisation and BNP correlation